Table 3.
Means, standard deviations, statistical significance, and effect sizes between groups for stress, quality of life, sleep problems, and functional impairment at pre, post, and 6-month follow-up.
| Measure | n | Pre | Post | 6 months | Group-by-time interaction effect (within-subjects) | Pre–post | Post 6 months | |
|---|---|---|---|---|---|---|---|---|
| NeuroACT = 16 TAU = 18 |
M (SD) | M (SD) | M (SD) | ANOVA | d | d | d | |
| PSS | NeuroACT | 35.8 (7.5) | 24.9 (8.4) | 22.6 (8.1) | F (2, 64) = 4.60 | 0.76* | 1.02 ** | 0.40 |
| TAU | 34.2 (7.7) | 32.3 (8.6) | 28.8 (8.1) | |||||
| SWLS | NeuroACT | 14.3 (5.1) | 18.7 (5.9) | 20.3 (5.6) | F (2, 64) = 3.85 | 0.77* | 0.69 | 0.71 |
| TAU | 14.4 (4.9) | 15.4 (6.2) | 16.4 (5.7) | |||||
| QOLI | NeuroACT | 0.70 (1.6) | 1.67 (1.4) | 1.41 (1.7) | F (2, 64) = 1.35 | 0.41 | 0.50 | 0.26 |
| TAU | −0.21 (1.5) | 0.12 (1.9) | 0.44 (1.7) | |||||
| KSQ-S | NeuroACT | 10.8 (6.6) | 7.7 (6.6) | 6.9 (5.1) | F (2, 64) = 3.12 | 0.63 | 0.78 | 0.11 |
| TAU | 9.2 (6.5) | 9.8 (5.5) | 7.5 (5.0) | |||||
| KSQ-A | NeuroACT | 7.8 (4.4) | 7.4 (4.5) | 5.7 (5.1) | F (2, 64) = 0.57 | 0.26 | 0.19 | 0.37 |
| TAU | 7.3 (4.6) | 7.8 (4.5) | 6.7 (3.8) | |||||
| SDS | NeuroACT | 17.6 (6.1) | 14.6 (4.9) | 15.1 (7.3) | F (2, 64) = 1.47 | 0.43 | 0.59 | 0.09 |
| TAU | 19.4 (6.5) | 19.7 (5.4) | 19.1 (5.9) | |||||
ANOVA: analysis of variance; PSS: Perceived Stress Scale; SWLS: Satisfaction with Life Scale; QOLI: Quality of Life Inventory; BDI-II: Beck Depression Inventory–II; KSQ-S: Karolinska Sleep Questionnaire–Sleep quality Index; KSQ-A: Karolinska Sleep Questionnaire–Awakening Index; SDS: Sheehan Disability Scale. Effect size measured by Cohen’s d (0.2 = small; 0.5 = moderate; 0.8 = large).
*
p < 0.05. **p < 0.01.